Literature DB >> 21324399

Attenuation of reperfusion-induced hepatocyte apoptosis is associated with reversed bcl-2/bax ratio in hemi-hepatic artery-preserved portal occlusion.

Shan Jin1, Chao-Liu Dai.   

Abstract

BACKGROUND: This study aimed to examine the hepatocyte apoptosis in a hepatic blood inflow occlusion rat model without hemi-hepatic arterial control and its association with the expressions of the apoptosis-regulating genes bcl-2 and bax.
MATERIALS AND METHODS: Wistar rats were equally and randomly assigned to undergo sham operation (control group, n = 8), Pringle's maneuver (group PR, n = 32), hemi-hepatic occlusion (group HH, n = 32), or hemi-hepatic artery-preserved portal occlusion (group HP, n = 32). The hepatic blood inflow was interrupted for 30 min using a microvascular clip in the three experimental groups. The clips were removed to achieve hepatic reperfusion for up to 24 h. Blood samples and liver specimens were collected following reperfusion to perform pathologic examination, serum transferase assay, apoptosis analysis, and determination of bcl-2 and bax mRNA and protein expressions.
RESULTS: The reperfusion-related hepatocytic injuries were more severe in the PR group than in the HH and HP groups, both pathologically and biochemically. More reperfused hepatocytes became apoptotic in the PR group than in the HH and HP groups. However, the values of the HH and HP groups were comparable in cellularity, levels of serum transferases, and apoptosis rate following reperfusion. The ratios of bcl-2/bax were reversed, which was more evident in the HH and HP groups than in the PR group.
CONCLUSION: Hemi-hepatic artery-preserved portal occlusion had little effect on hepatocyte apoptosis compared with Pringle's maneuver and caused minor ischemia-reperfusion injury as shown by the reversed bcl-2/bax ratio.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21324399     DOI: 10.1016/j.jss.2010.12.030

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  7 in total

Review 1.  Management of post-hepatectomy complications.

Authors:  Shan Jin; Quan Fu; Gerile Wuyun; Tu Wuyun
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

2.  Independent of Calorie Intake, Short-term Alternate-day Fasting Alleviates NASH, With Modulation of Markers of Lipogenesis, Autophagy, Apoptosis, and Inflammation in Rats.

Authors:  Hassan Reda Hassan Elsayed; Mohammad El-Nablaway; Basma Adel Khattab; Rania N Sherif; Wagdi Fawzy Elkashef; Asim Mohammed Abdalla; Eman Mohammad El Nashar; Mostafa Mohammed Abd-Elmonem; Randa El-Gamal
Journal:  J Histochem Cytochem       Date:  2021-08-27       Impact factor: 4.137

3.  Protection of rat liver against hepatic ischemia-reperfusion injury by a novel selenocysteine-containing 7-mer peptide.

Authors:  Qianqian Jiang; Yu Pan; Yupeng Cheng; Huiling Li; Hui Li
Journal:  Mol Med Rep       Date:  2016-07-01       Impact factor: 2.952

4.  Pien Tze Huang Gan Bao attenuates carbon tetrachloride‑induced hepatocyte apoptosis in rats, associated with suppression of p53 activation and oxidative stress.

Authors:  Jinyan Zhao; Yuchen Zhang; Yun Wan; Haixia Hu; Zhenfeng Hong
Journal:  Mol Med Rep       Date:  2017-07-06       Impact factor: 2.952

5.  Regional Ischemic Preconditioning Has Clinical Value in Cirrhotic HCC Through MAPK Pathways.

Authors:  Liming Wang; Li Feng; Weiqi Rong; Mei Liu; Fan Wu; Weibo Yu; Songlin An; Xiang Zhou; Jianxiong Wu
Journal:  J Gastrointest Surg       Date:  2018-12-12       Impact factor: 3.452

6.  Daphnoretin induces reactive oxygen species-mediated apoptosis in melanoma cells.

Authors:  Hui Wang; Xue Hu; Minjing Li; Zhaohai Pan; Defang Li; Qiusheng Zheng
Journal:  Oncol Lett       Date:  2021-04-08       Impact factor: 2.967

7.  Hypoxia-inducible factor-1alpha protects the liver against ischemia-reperfusion injury by regulating the A2B adenosine receptor.

Authors:  Xingjian Zhang; Peng Du; Kaifeng Luo; Yong Li; Zhongzhong Liu; Wei Wang; Cheng Zeng; Qifa Ye; Qi Xiao
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.